Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Pemetrexed 500 / Carboplatin 5 / Amivantamab 1750, Non-Small Cell Lung Cancer, Cycle 3-4

Protocol-ID: 2500 V1.0 (Mini), PEME500/CRBP5/AMIV1750, NSCLC, C3-4

Indication(s)

  • Lung Carcinoma, Non-Small Cell (EGFR exon 20 insertion); ICD-10 C34.-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 04.01.2024